| Conjugate | Catalog # | Availability | Size | Price |
|---|---|---|---|---|
| Alexa Fluor Plus 488 | NBP3-49493AFP488 | |||
| Alexa Fluor Plus 555 | NBP3-49493AFP555 | |||
| Alexa Fluor Plus 594 | NBP3-49493AFP594 | |||
| Alexa Fluor Plus 647 | NBP3-49493AFP647 | |||
| Alexa Fluor Plus 680 | NBP3-49493AFP680 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-14758SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-70407 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-71006 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-43338-0.5mg | |||
| BSA Free | NBP1-43338-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-70382 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-70381 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-71076 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-43385-0.5mg | |||
| BSA Free | NBP1-43385-0.05mg | |||
| Conjugate | Catalog # | Availability | Size | Price |
|---|---|---|---|---|
| Biotin | NBP1-43546-0.5mg | |||
| Biotin | NBP1-43546-0.1mg | |||
| PE/Cy5 | NBP1-43068-0.1mg | |||
| PE/Cy7 | NBP1-42940-0.1mg | |||
| PE/Cy7 | NBP1-42940-0.05mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-43303-0.1mg | |||
| BSA Free | NBP1-43303-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-70378 | |||
![Western Blot: CD3 epsilon Antibody (BLR174J) [NBP3-14747] - Whole cell lysate (10 ug) from BW5147.3, NIH 3T3, TCMK-1, and EL4 cells prepared using NETN lysis buffer. Rabbit anti-CD3E recombinant monoclonal antibody [BLR174J] used at 1:1000.](http://images.novusbio.com/fullsize/CD3-epsilon-Antibody-BLR174J-Western-Blot-NBP3-14747-img0003.jpg "Western Blot: CD3 epsilon Antibody (BLR174J) [NBP3-14747] - Whole cell lysate (10 ug) from BW5147.3, NIH 3T3, TCMK-1, and EL4 cells prepared using NETN lysis buffer. Rabbit anti-CD3E recombinant monoclonal antibody [BLR174J] used at 1:1000.")
![Immunohistochemistry: CD3 epsilon Antibody (BLR174J) [NBP3-14747] - Rabbit anti-CD3E recombinant monoclonal antibody. HRP-conjugated goat anti-rabbit IgG.](http://images.novusbio.com/fullsize/CD3-epsilon-Antibody-BLR174J-Immunohistochemistry-NBP3-14747-img0002.jpg)
![Flow Cytometry: CD3 epsilon Antibody (BLR174J) [NBP3-14747] - Rabbit anti-CD3E recombinant monoclonal antibody or isotype control (unshaded).](http://images.novusbio.com/fullsize/CD3-epsilon-Antibody-BLR174J-Flow-Cytometry-NBP3-14747-img0001.jpg)
![Flow (Cell Surface): CD5 Antibody (7.8) [NBP3-14758] - A surface stain was performed on Jurkat (panel A) and Raw264.7 (panel B) cells with human specific CD5 Antibody (7.8) NBP3-14758 (blue) and a matched isotype control MAB003 (orange). Cells were incubated in an antibody dilution of 1.0 ug/mL for 20 minutes at room temperature, followed by Mouse IgG (H+L) Cross-Adsorbed Secondary Antibody, Dylight 550 (84540, Thermo Fisher).](http://images.novusbio.com/fullsize/CD5-Antibody-7-8-Flow-Cell-Surface-NBP3-14758-img0001.jpg "Flow (Cell Surface): CD5 Antibody (7.8) [NBP3-14758] - A surface stain was performed on Jurkat (panel A) and Raw264.7 (panel B) cells with human specific CD5 Antibody (7.8) NBP3-14758 (blue) and a matched isotype control MAB003 (orange). Cells were incubated in an antibody dilution of 1.0 ug/mL for 20 minutes at room temperature, followed by Mouse IgG (H+L) Cross-Adsorbed Secondary Antibody, Dylight 550 (84540, Thermo Fisher).")
![Western Blot: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CEACAM-5.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Western-Blot-NBP2-46231-img0018.jpg "Western Blot: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CEACAM-5.")
![Immunohistochemistry: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of Human tonsil tissue.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Immunohistochemistry-NBP2-46231-img0017.jpg)
![Immunohistochemistry: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of Human colon tissue.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Immunohistochemistry-NBP2-46231-img0001.jpg)
![Immunohistochemistry: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of Human Kidney tissue.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Immunohistochemistry-NBP2-46231-img0002.jpg)
![Immunohistochemistry: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of Human liver tissue.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Immunohistochemistry-NBP2-46231-img0003.jpg)
![Immunohistochemistry: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of Carcinoma of Human liver tissue.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Immunohistochemistry-NBP2-46231-img0004.jpg)
![Immunohistochemistry: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of Human lung tissue.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Immunohistochemistry-NBP2-46231-img0005.jpg)
![Immunohistochemistry: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of Carcinoma of Human lung tissue.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Immunohistochemistry-NBP2-46231-img0006.jpg)
![Immunohistochemistry: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of Adenocarcinoma of Human ovary tissue.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Immunohistochemistry-NBP2-46231-img0007.jpg)
![Immunohistochemistry: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of Human pancreas tissue.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Immunohistochemistry-NBP2-46231-img0008.jpg)
![Immunohistochemistry: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of Carcinoma of Human pancreas tissue.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Immunohistochemistry-NBP2-46231-img0009.jpg)
![Immunohistochemistry: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of Human endometrium tissue.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Immunohistochemistry-NBP2-46231-img0010.jpg)
![Immunohistochemistry: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of Human prostate tissue.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Immunohistochemistry-NBP2-46231-img0011.jpg)
![Immunohistochemistry: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of Carcinoma of Human prostate tissue.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Immunohistochemistry-NBP2-46231-img0012.jpg)
![Immunohistochemistry: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of Human bladder tissue.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Immunohistochemistry-NBP2-46231-img0013.jpg)
![Immunohistochemistry: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of Carcinoma of Human bladder tissue.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Immunohistochemistry-NBP2-46231-img0014.jpg)
![Immunohistochemistry: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of Human lymph node tissue.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Immunohistochemistry-NBP2-46231-img0015.jpg)
![Immunohistochemistry: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of Human lymphoma tissue.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Immunohistochemistry-NBP2-46231-img0016.jpg)
![Western Blot: IFIT3 Antibody (OTI1G1) [NBP2-02148] - Analysis of extracts (35ug) from 9 different cell lines by using anti-IFIT3 monoclonal antibody at 1:200 dilution. (HepG2: human; HeLa: human; SVT2: mouse; A549: human; COS7: monkey; Jurkat: human; MDCK: canine; PC12: rat; MCF7: human)](http://images.novusbio.com/fullsize/IFIT3-Antibody-OTI1G1-Western-Blot-NBP2-02148-img0010.jpg "Western Blot: IFIT3 Antibody (OTI1G1) [NBP2-02148] - Analysis of extracts (35ug) from 9 different cell lines by using anti-IFIT3 monoclonal antibody at 1:200 dilution. (HepG2: human; HeLa: human; SVT2: mouse; A549: human; COS7: monkey; Jurkat: human; MDCK: canine; PC12: rat; MCF7: human)")
![Immunocytochemistry/Immunofluorescence: IFIT3 Antibody (OTI1G1) [NBP2-02148] - Staining of COS7 cells transiently transfected by pCMV6-ENTRY IFIT3.](http://images.novusbio.com/fullsize/IFIT3-Antibody-1G1-Immunocytochemistry-Immunofluorescence-NBP2-02148-img0009.jpg)
![Flow Cytometry: IFIT3 Antibody (1G1) [NBP2-02148] - Analysis of Jurkat cells, using anti-IFIT3 antibody, (Red) compared to a nonspecific negative control antibody (Blue).](http://images.novusbio.com/fullsize/IFIT3-Antibody-1G1-Flow-Cytometry-NBP2-02148-img0001.jpg)
![Western Blot: IFIT3 Antibody (1G1) [NBP2-02148] - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY IFIT3 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-IFIT3.](http://images.novusbio.com/fullsize/IFIT3-Antibody-1G1-Western-Blot-NBP2-02148-img0002.jpg)
![Immunocytochemistry/Immunofluorescence: IFIT3 Antibody (1G1) [NBP2-02148] - Immunofluorescent staining of HT29 cells using anti-IFIT3 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/IFIT3-Antibody-1G1-Immunocytochemistry-Immunofluorescence-NBP2-02148-img0003.jpg)
![IFIT3 Antibody (OTI1G1)[NBP2-02148]Simple Western� analysis of endogenous protein GBE1 from SH-SY5Y lysates (0.1mg/mL) using GBE1 Mouse Monoclonal Antibody . The virtual lane view (left) shows the target (as indicated) at a 1:50 dilution of primary antibody. The corresponding electropherogram view (right) plots chemiluminescence by molecular weight along the capillary at a 1:50 dilution of primary antibody. This experiment was performed under reducing conditions on the Jess� Simple Western instrument from ProteinSimple, a Bio-Techne brand, using the 12�230 kDa Separation Module.](http://images.novusbio.com/fullsize/nbp2-02148_mouse-ifit3-mab-oti1g1-simple-western-131120251236354.jpg%253fstore=america&image-type=image)
![Immunohistochemistry-Paraffin: CXCR2/IL-8 RB Antibody (5E8-C7-F10) [NBP1-43338] - CXCR2positive breast cancer cells in the human brain. CXCR2-red fluorochrome, nucleus-DAPI. Antibody used at dilution of 1:100. This image was submitted via customer Review.](http://images.novusbio.com/fullsize/CXCR2-IL-8-RB-Antibody-5E8-C7-F10-Immunohistochemistry-Paraffin-NBP1-43338-img0005.jpg "Immunohistochemistry-Paraffin: CXCR2/IL-8 RB Antibody (5E8-C7-F10) [NBP1-43338] - CXCR2positive breast cancer cells in the human brain. CXCR2-red fluorochrome, nucleus-DAPI. Antibody used at dilution of 1:100. This image was submitted via customer Review.")
![Flow Cytometry: CXCR2/IL-8 RB Antibody (5E8-C7-F10) [NBP1-43338] - Analysis using the PE conjugate of NBP1-43338. Staining of normal human peripheral blood cells with Anti-Human CD4 APC (left) or Anti-Human CD56 (NCAM) APC (right) and Anti-Human CD182 (CXCR2) PE. Cells in the lymphocyte gate were used for analysis.](http://images.novusbio.com/fullsize/CXCR2-IL-8-RB-Antibody-5E8-C7-F10-Flow-Cytometry-NBP1-43338-img0004.jpg)
![Flow Cytometry: CXCR2/IL-8 RB Antibody (5E8-C7-F10) [NBP1-43338] - Staining of normal human peripheral blood cells with 0.25 ug of Mouse IgG1 kappa Isotype Control Purified (left) or 0.25 ug of Anti-Human CD182 (CXCR2) Purified (right) followed by F(ab')2 Anti-Mouse IgG PE . Cells in the large scatter population were used for analysis.](http://images.novusbio.com/fullsize/CXCR2-IL-8-RB-Antibody-5E8-C7-F10-Flow-Cytometry-NBP1-43338-img0002.jpg)
![Western Blot: CD74 Antibody (1H3) [NBP2-46179] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CD74.](http://images.novusbio.com/fullsize/CD74-Antibody-1H3-Western-Blot-NBP2-46179-img0008.jpg "Western Blot: CD74 Antibody (1H3) [NBP2-46179] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CD74.")
![Immunohistochemistry: CD74 Antibody (1H3) [NBP2-46179] - Analysis of Human lymphoma tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/CD74-Antibody-1H3-Immunohistochemistry-NBP2-46179-img0007.jpg)
![Immunohistochemistry: CD74 Antibody (1H3) [NBP2-46179] - Analysis of Human Kidney tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/CD74-Antibody-1H3-Immunohistochemistry-NBP2-46179-img0001.jpg)
![Immunohistochemistry: CD74 Antibody (1H3) [NBP2-46179] - Analysis of Adenocarcinoma of Human ovary tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/CD74-Antibody-1H3-Immunohistochemistry-NBP2-46179-img0002.jpg)
![Immunohistochemistry: CD74 Antibody (1H3) [NBP2-46179] - Analysis of Human endometrium tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/CD74-Antibody-1H3-Immunohistochemistry-NBP2-46179-img0003.jpg)
![Immunohistochemistry: CD74 Antibody (1H3) [NBP2-46179] - Analysis of Adenocarcinoma of Human endometrium tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/CD74-Antibody-1H3-Immunohistochemistry-NBP2-46179-img0004.jpg)
![Immunohistochemistry: CD74 Antibody (1H3) [NBP2-46179] - Analysis of Carcinoma of Human bladder tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/CD74-Antibody-1H3-Immunohistochemistry-NBP2-46179-img0005.jpg)
![Immunohistochemistry: CD74 Antibody (1H3) [NBP2-46179] - Analysis of Human lymph node tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/CD74-Antibody-1H3-Immunohistochemistry-NBP2-46179-img0006.jpg)
![Immunohistochemistry: CD68/SR-D1 Antibody (OTI1E6) [NBP2-46168] - CD68/SR-D1 Antibody (1E6) [NBP2-46168] - Analysis of Human lymph node tissue.](http://images.novusbio.com/fullsize/CD68-SR-D1-Antibody-1E6-Immunohistochemistry-NBP2-46168-img0010.jpg "Immunohistochemistry: CD68/SR-D1 Antibody (OTI1E6) [NBP2-46168] - CD68/SR-D1 Antibody (1E6) [NBP2-46168] - Analysis of Human lymph node tissue.")
![Immunohistochemistry: CD68/SR-D1 Antibody (OTI1E6) [NBP2-46168] - CD68/SR-D1 Antibody (1E6) [NBP2-46168] - Analysis of Human lymphoma tissue.](http://images.novusbio.com/fullsize/CD68-SR-D1-Antibody-1E6-Immunohistochemistry-NBP2-46168-img0011.jpg)
![Western Blot: CD68/SR-D1 Antibody (1E6) [NBP2-46168] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CD68.](http://images.novusbio.com/fullsize/CD68-SR-D1-Antibody-1E6-Western-Blot-NBP2-46168-img0013.jpg)
![Immunohistochemistry: CD68/SR-D1 Antibody (1E6) [NBP2-46168] - Analysis of Human tonsil tissue.](http://images.novusbio.com/fullsize/CD68-SR-D1-Antibody-1E6-Immunohistochemistry-NBP2-46168-img0012.jpg)
![Immunohistochemistry: CD68/SR-D1 Antibody (1E6) [NBP2-46168] - Analysis of Adenocarcinoma of Human breast tissue.](http://images.novusbio.com/fullsize/CD68-SR-D1-Antibody-1E6-Immunohistochemistry-NBP2-46168-img0001.jpg)
![Immunohistochemistry: CD68/SR-D1 Antibody (1E6) [NBP2-46168] - Analysis of Adenocarcinoma of Human colon tissue.](http://images.novusbio.com/fullsize/CD68-SR-D1-Antibody-1E6-Immunohistochemistry-NBP2-46168-img0002.jpg)
![Immunohistochemistry: CD68/SR-D1 Antibody (1E6) [NBP2-46168] - Analysis of Human Kidney tissue.](http://images.novusbio.com/fullsize/CD68-SR-D1-Antibody-1E6-Immunohistochemistry-NBP2-46168-img0003.jpg)
![Immunohistochemistry: CD68/SR-D1 Antibody (1E6) [NBP2-46168] - Analysis of Carcinoma of Human kidney tissue.](http://images.novusbio.com/fullsize/CD68-SR-D1-Antibody-1E6-Immunohistochemistry-NBP2-46168-img0004.jpg)
![Immunohistochemistry: CD68/SR-D1 Antibody (1E6) [NBP2-46168] - Analysis of Human liver tissue.](http://images.novusbio.com/fullsize/CD68-SR-D1-Antibody-1E6-Immunohistochemistry-NBP2-46168-img0005.jpg)
![Immunohistochemistry: CD68/SR-D1 Antibody (1E6) [NBP2-46168] - Analysis of Carcinoma of Human lung tissue.](http://images.novusbio.com/fullsize/CD68-SR-D1-Antibody-1E6-Immunohistochemistry-NBP2-46168-img0006.jpg)
![Immunohistochemistry: CD68/SR-D1 Antibody (1E6) [NBP2-46168] - Analysis of Adenocarcinoma of Human ovary tissue.](http://images.novusbio.com/fullsize/CD68-SR-D1-Antibody-1E6-Immunohistochemistry-NBP2-46168-img0007.jpg)
![Immunohistochemistry: CD68/SR-D1 Antibody (1E6) [NBP2-46168] - Analysis of Carcinoma of Human pancreas tissue.](http://images.novusbio.com/fullsize/CD68-SR-D1-Antibody-1E6-Immunohistochemistry-NBP2-46168-img0008.jpg)
![Immunohistochemistry: CD68/SR-D1 Antibody (1E6) [NBP2-46168] - Analysis of Human bladder tissue.](http://images.novusbio.com/fullsize/CD68-SR-D1-Antibody-1E6-Immunohistochemistry-NBP2-46168-img0009.jpg)
![Western Blot: CD117/c-kit Antibody (2B12) [NBP2-45508] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CD117.](http://images.novusbio.com/fullsize/CD117-c-kit-Antibody-2B12-Western-Blot-NBP2-45508-img0013.jpg "Western Blot: CD117/c-kit Antibody (2B12) [NBP2-45508] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CD117.")
![Immunohistochemistry: CD117/c-kit Antibody (2B12) [NBP2-45508] - Analysis of Human lymphoma tissue. (Heat-induced epitope retrieval by 1mM EDTA in 10mM Tris buffer (pH8.5) at 120C for 3 min)](http://images.novusbio.com/fullsize/CD117-c-kit-Antibody-2B12-Immunohistochemistry-NBP2-45508-img0012.jpg)
![Immunohistochemistry: CD117/c-kit Antibody (2B12) [NBP2-45508] - Analysis of Human colon tissue. (Heat-induced epitope retrieval by 1mM EDTA in 10mM Tris buffer (pH8.5) at 120C for 3 min)](http://images.novusbio.com/fullsize/CD117-c-kit-Antibody-2B12-Immunohistochemistry-NBP2-45508-img0001.jpg)
![Immunohistochemistry: CD117/c-kit Antibody (2B12) [NBP2-45508] - Analysis of Adenocarcinoma of Human colon tissue. (Heat-induced epitope retrieval by 1mM EDTA in 10mM Tris buffer (pH8.5) at 120C for 3 min)](http://images.novusbio.com/fullsize/CD117-c-kit-Antibody-2B12-Immunohistochemistry-NBP2-45508-img0002.jpg)
![Immunohistochemistry: CD117/c-kit Antibody (2B12) [NBP2-45508] - Analysis of Human Kidney tissue. (Heat-induced epitope retrieval by 1mM EDTA in 10mM Tris buffer (pH8.5) at 120C for 3 min)](http://images.novusbio.com/fullsize/CD117-c-kit-Antibody-2B12-Immunohistochemistry-NBP2-45508-img0003.jpg)
![Immunohistochemistry: CD117/c-kit Antibody (2B12) [NBP2-45508] - Analysis of Carcinoma of Human liver tissue.(Heat-induced epitope retrieval by 1mM EDTA in 10mM Tris buffer (pH8.5) at 120C for 3 min)](http://images.novusbio.com/fullsize/CD117-c-kit-Antibody-2B12-Immunohistochemistry-NBP2-45508-img0004.jpg)
![Immunohistochemistry: CD117/c-kit Antibody (2B12) [NBP2-45508] - Analysis of Carcinoma of Human lung tissue. (Heat-induced epitope retrieval by 1mM EDTA in 10mM Tris buffer (pH8.5) at 120C for 3 min)](http://images.novusbio.com/fullsize/CD117-c-kit-Antibody-2B12-Immunohistochemistry-NBP2-45508-img0005.jpg)
![Immunohistochemistry: CD117/c-kit Antibody (2B12) [NBP2-45508] - Analysis of Human pancreas tissue. (Heat-induced epitope retrieval by 1mM EDTA in 10mM Tris buffer (pH8.5) at 120C for 3 min)](http://images.novusbio.com/fullsize/CD117-c-kit-Antibody-2B12-Immunohistochemistry-NBP2-45508-img0006.jpg)
![Immunohistochemistry: CD117/c-kit Antibody (2B12) [NBP2-45508] - Analysis of Carcinoma of Human thyroid tissue. (Heat-induced epitope retrieval by 1mM EDTA in 10mM Tris buffer (pH8.5) at 120C for 3 min)](http://images.novusbio.com/fullsize/CD117-c-kit-Antibody-2B12-Immunohistochemistry-NBP2-45508-img0007.jpg)
![Immunohistochemistry: CD117/c-kit Antibody (2B12) [NBP2-45508] - Analysis of Human endometrium tissue. (Heat-induced epitope retrieval by 1mM EDTA in 10mM Tris buffer (pH8.5) at 120C for 3 min)](http://images.novusbio.com/fullsize/CD117-c-kit-Antibody-2B12-Immunohistochemistry-NBP2-45508-img0008.jpg)
![Immunohistochemistry: CD117/c-kit Antibody (2B12) [NBP2-45508] - Analysis of Carcinoma of Human prostate tissue. (Heat-induced epitope retrieval by 1mM EDTA in 10mM Tris buffer (pH8.5) at 120C for 3 min)](http://images.novusbio.com/fullsize/CD117-c-kit-Antibody-2B12-Immunohistochemistry-NBP2-45508-img0009.jpg)
![Immunohistochemistry: CD117/c-kit Antibody (2B12) [NBP2-45508] - Analysis of Human bladder tissue. (Heat-induced epitope retrieval by 1mM EDTA in 10mM Tris buffer (pH8.5) at 120C for 3 min)(1:150)](http://images.novusbio.com/fullsize/CD117-c-kit-Antibody-2B12-Immunohistochemistry-NBP2-45508-img0010.jpg)
![Immunohistochemistry: CD117/c-kit Antibody (2B12) [NBP2-45508] - Analysis of Carcinoma of Human bladder tissue.(Heat-induced epitope retrieval by 1mM EDTA in 10mM Tris buffer (pH8.5) at 120C for 3 min)](http://images.novusbio.com/fullsize/CD117-c-kit-Antibody-2B12-Immunohistochemistry-NBP2-45508-img0011.jpg)
![Flow Cytometry: B7-1/CD80 Antibody (16-10A1) [NBP1-43385] - Analysis using the PE/Cy5 conjugate of NBP1-43385. Staining of 3-day LPS activated C57Bl/6 splenocytes with 0.03 ug of PE-Cy5 Armenian Hamster IgG Isotype Control (open histogram) or 0.03 ug of Anti-Mouse CD80 (B7-1) PE-Cy5 (filled histogram). Total cells](http://images.novusbio.com/fullsize/B7-1-CD80-Antibody-16-10A1-Flow-Cytometry-NBP1-43385-img0007.jpg "Flow Cytometry: B7-1/CD80 Antibody (16-10A1) [NBP1-43385] - Analysis using the PE/Cy5 conjugate of NBP1-43385. Staining of 3-day LPS activated C57Bl/6 splenocytes with 0.03 ug of PE-Cy5 Armenian Hamster IgG Isotype Control (open histogram) or 0.03 ug of Anti-Mouse CD80 (B7-1) PE-Cy5 (filled histogram). Total cells")
![Flow Cytometry: B7-1/CD80 Antibody (16-10A1) [NBP1-43385] - Staining of 3-day LPS-stimulated BALB/c splenocytes with 0.25 ug of Armenian Hamster IgG Isotype Control Purified (open histogram) or 0.25 ug of Anti-Mouse CD80 (B7-1) Purified (filled histogram) followed by Anti-Armenian Hamster IgG FITC. Total viable cells were used for analysis.](http://images.novusbio.com/fullsize/B7-1-CD80-Antibody-16-10A1-Flow-Cytometry-NBP1-43385-img0001.jpg)
![Flow Cytometry: B7-1/CD80 Antibody (16-10A1) [NBP1-43385] - Analysis using the Biotin conjugate of NBP1-43385. Staining of 3-day LPS-stimulated C57BL/6 splenocytes with 0.06 ug of Armenian Hamster IgG Isotype Control Biotin (open histogram) or 0.06 ug of Anti-Mouse CD80 (B7-1) Biotin (filled histogram) followed by Streptavidin PE. Total viable cells were used for analysis.](http://images.novusbio.com/fullsize/B7-1-CD80-Antibody-16-10A1-Flow-Cytometry-NBP1-43385-img0004.jpg)
![Flow Cytometry: B7-1/CD80 Antibody (16-10A1) [NBP1-43385] - Analysis using the FITC conjugate of NBP1-43385. Staining of unstimulated (left) or 3-day LPS-stimulated (right) C57BL/6 splenocytes with 0.125 ug of Anti-Mouse CD80 (B7-1) FITC. Total viable cells were used for analysis. Markers were set based on the autofluorescence sample.](http://images.novusbio.com/fullsize/B7-1-CD80-Antibody-16-10A1-Flow-Cytometry-NBP1-43385-img0005.jpg)
![Flow Cytometry: B7-1/CD80 Antibody (16-10A1) [NBP1-43385] - Analysis using the PE conjugate of NBP1-43385. See Notes](http://images.novusbio.com/fullsize/B7-1-CD80-Antibody-16-10A1-Flow-Cytometry-NBP1-43385-img0006.jpg)
![Flow Cytometry: Armenian Hamster Monoclonal B7-1/CD80 Antibody (16-10A1) [NBP1-43385] - Alexa Fluor® 488 conjugated antibody (Catalog # NBP1-43385AF488) was tested via flow cytometry using magnetic beads coated with feline protein. Histogram overlay showing fluorescence results obtained via flow cytometry. Red line (unstained beads) and green line (beads coated with CD86 synthetic protein) served as negative controls. Blue line: positive signal obtained with CD80-coated beads. Image from a verified customer review.](http://images.novusbio.com/fullsize/antibody/nbp1-43385_armenian-hamster-monoclonal-b7-1-cd80-antibody-16-10a1-flow-cytometry-199202495917..png)
![Flow Cytometry: IgM Antibody (II/41) [NBP1-43303] - Analysis of PE/Cy7 conjugate of NBP1-43303. Staining of C57BL/6 bone marrow cells with Anti-Human/Mouse CD45R (B220) FITC and 0.06 micrograms of Rat IgG2a ? Isotype Control PE-Cy7 (left) or 0.06 micrograms of Anti-Mouse IgM PE-Cy7 (right). Cells in the ly](http://images.novusbio.com/fullsize/Mouse-IgM-Antibody-II-41-Flow-Cytometry-NBP1-43303-img0008.jpg "Flow Cytometry: IgM Antibody (II/41) [NBP1-43303] - Analysis of PE/Cy7 conjugate of NBP1-43303. Staining of C57BL/6 bone marrow cells with Anti-Human/Mouse CD45R (B220) FITC and 0.06 micrograms of Rat IgG2a ? Isotype Control PE-Cy7 (left) or 0.06 micrograms of Anti-Mouse IgM PE-Cy7 (right). Cells in the ly")
![Flow Cytometry: IgM Antibody (II/41) [NBP1-43303] - Staining of C57BL/6 splenocytes with 0.5 ug of Rat IgG2a kappa Isotype Control Purified (open histogram) or 0.5 ug of Anti-Mouse IgM Purified (filled histogram) followed by Anti-Rat IgG Biotin and Streptavidin PE. Total viable cells were used for analysis.](http://images.novusbio.com/fullsize/Mouse-IgM-Antibody-II-41-Flow-Cytometry-NBP1-43303-img0001.jpg)
![Flow Cytometry: IgM Antibody (II/41) [NBP1-43303] - Analysis of Allophycocyanin conjugate of NBP1-43303. Staining of C57Bl/6 bone marrow cells with Anti-Human/Mouse CD45R (B220) FITC and 0.125 ug of Rat IgG2a K Isotype Control APC (left) or 0.125 ug of Anti-Mouse IgM APC (right). Cells in the small scatter](http://images.novusbio.com/fullsize/Mouse-IgM-Antibody-II-41-Flow-Cytometry-NBP1-43303-img0002.jpg)
![Flow Cytometry: IgM Antibody (II/41) [NBP1-43303] - Analysis of Allophycocyanin conjugate of NBP1-43303. Staining of C57Bl/6 bone marrow cells with Anti-Human/Mouse CD45R (B220) FITC and 0.125 ug of Rat IgG2a K Isotype Control APC (left) or 0.125 ug of Anti-Mouse IgM APC (right). Cells in the small scatter](http://images.novusbio.com/fullsize/Mouse-IgM-Antibody-II-41-Flow-Cytometry-NBP1-43303-img0003.jpg)
![Flow Cytometry: IgM Antibody (II/41) [NBP1-43303] - Analysis of Biotin conjugate of NBP1-43303. Staining of C57BL/6 bone marrow cells with Anti-Human/Mouse CD45R (B220) APC and 0.06 ug of Rat IgG2a kappa Isotype Control Biotin (left) or 0.06 ug of Anti-Mouse IgM Biotin (right) followed by Streptavidin PE .](http://images.novusbio.com/fullsize/Mouse-IgM-Antibody-II-41-Flow-Cytometry-NBP1-43303-img0004.jpg)
![Flow Cytometry: IgM Antibody (II/41) [NBP1-43303] - Analysis of FITC conjugate of NBP1-43303. Staining of C57BL/6 bone marrow cells with Anti-Human/Mouse CD45R (B220) APC and 0.125 ug of Rat IgG2a K Isotype Control FITC (left) or 0.125 ug of Anti-Mouse IgM FITC (right). Total viable cells were used for ana](http://images.novusbio.com/fullsize/Mouse-IgM-Antibody-II-41-Flow-Cytometry-NBP1-43303-img0005.jpg)
![Flow Cytometry: IgM Antibody (II/41) [NBP1-43303] - Analysis of PE conjugate of NBP1-43303. The II/41 antibody has been tested by flow cytometric mouse spleen cell suspension. This can be used at less than or equal to 1 ug per test. Cell number should be determined empirically but can range from 10^5to 10^](http://images.novusbio.com/fullsize/Mouse-IgM-Antibody-II-41-Flow-Cytometry-NBP1-43303-img0006.jpg)
![Flow Cytometry: IgM Antibody (II/41) [NBP1-43303] - Analysis of PE/Cy5 conjugate of NBP1-43303. Staining of C57Bl/6 bone marrow cells with Anti-Human/Mouse CD45R (B220) FITC and 0.06 ug of Rat IgG2a Isotype Control PE-Cy5 (left) or 0.06 ug of Anti-Mouse IgM PE-Cy5 (right). Total viable cells were used for](http://images.novusbio.com/fullsize/Mouse-IgM-Antibody-II-41-Flow-Cytometry-NBP1-43303-img0007.jpg)
![Western Blot: CD40/TNFRSF5 Antibody (8B8) [NBP2-46150] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CD40.](http://images.novusbio.com/fullsize/CD40-TNFRSF5-Antibody-8B8-Western-Blot-NBP2-46150-img0013.jpg "Western Blot: CD40/TNFRSF5 Antibody (8B8) [NBP2-46150] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CD40.")
![Immunohistochemistry: CD40/TNFRSF5 Antibody (8B8) [NBP2-46150] - Analysis of Human tonsil tissue. (Heat-induced epitope retrieval by Tris-EDTA, pH8.0)](http://images.novusbio.com/fullsize/CD40-TNFRSF5-Antibody-8B8-Immunohistochemistry-NBP2-46150-img0012.jpg)
![Immunohistochemistry: CD40/TNFRSF5 Antibody (8B8) [NBP2-46150] - Analysis of Human breast tissue. (Heat-induced epitope retrieval by Tris-EDTA, pH8.0)](http://images.novusbio.com/fullsize/CD40-TNFRSF5-Antibody-8B8-Immunohistochemistry-NBP2-46150-img0001.jpg)
![Immunohistochemistry: CD40/TNFRSF5 Antibody (8B8) [NBP2-46150] - Analysis of Adenocarcinoma of Human breast tissue. (Heat-induced epitope retrieval by Tris-EDTA, pH8.0)](http://images.novusbio.com/fullsize/CD40-TNFRSF5-Antibody-8B8-Immunohistochemistry-NBP2-46150-img0002.jpg)
![Immunohistochemistry: CD40/TNFRSF5 Antibody (8B8) [NBP2-46150] - Analysis of Human colon tissue. (Heat-induced epitope retrieval by Tris-EDTA, pH8.0)](http://images.novusbio.com/fullsize/CD40-TNFRSF5-Antibody-8B8-Immunohistochemistry-NBP2-46150-img0003.jpg)
![Immunohistochemistry: CD40/TNFRSF5 Antibody (8B8) [NBP2-46150] - Analysis of Human Kidney tissue. (Heat-induced epitope retrieval by Tris-EDTA, pH8.0)](http://images.novusbio.com/fullsize/CD40-TNFRSF5-Antibody-8B8-Immunohistochemistry-NBP2-46150-img0004.jpg)
![Immunohistochemistry: CD40/TNFRSF5 Antibody (8B8) [NBP2-46150] - Analysis of Carcinoma of Human kidney tissue. (Heat-induced epitope retrieval by Tris-EDTA, pH8.0)](http://images.novusbio.com/fullsize/CD40-TNFRSF5-Antibody-8B8-Immunohistochemistry-NBP2-46150-img0005.jpg)
![Immunohistochemistry: CD40/TNFRSF5 Antibody (8B8) [NBP2-46150] - Analysis of Carcinoma of Human liver tissue. (Heat-induced epitope retrieval by Tris-EDTA, pH8.0)](http://images.novusbio.com/fullsize/CD40-TNFRSF5-Antibody-8B8-Immunohistochemistry-NBP2-46150-img0006.jpg)
![Immunohistochemistry: CD40/TNFRSF5 Antibody (8B8) [NBP2-46150] - Analysis of Adenocarcinoma of Human ovary tissue. (Heat-induced epitope retrieval by Tris-EDTA, pH8.0)](http://images.novusbio.com/fullsize/CD40-TNFRSF5-Antibody-8B8-Immunohistochemistry-NBP2-46150-img0007.jpg)
![Immunohistochemistry: CD40/TNFRSF5 Antibody (8B8) [NBP2-46150] - Analysis of Human pancreas tissue. (Heat-induced epitope retrieval by Tris-EDTA, pH8.0)](http://images.novusbio.com/fullsize/CD40-TNFRSF5-Antibody-8B8-Immunohistochemistry-NBP2-46150-img0008.jpg)
![Immunohistochemistry: CD40/TNFRSF5 Antibody (8B8) [NBP2-46150] - Analysis of Adenocarcinoma of Human endometrium tissue. (Heat-induced epitope retrieval by Tris-EDTA, pH8.0)](http://images.novusbio.com/fullsize/CD40-TNFRSF5-Antibody-8B8-Immunohistochemistry-NBP2-46150-img0009.jpg)
![Immunohistochemistry: CD40/TNFRSF5 Antibody (8B8) [NBP2-46150] - Analysis of Carcinoma of Human prostate tissue. (Heat-induced epitope retrieval by Tris-EDTA, pH8.0)](http://images.novusbio.com/fullsize/CD40-TNFRSF5-Antibody-8B8-Immunohistochemistry-NBP2-46150-img0010.jpg)
![Immunohistochemistry: CD40/TNFRSF5 Antibody (8B8) [NBP2-46150] - Analysis of Human lymphoma tissue. (Heat-induced epitope retrieval by Tris-EDTA, pH8.0)](http://images.novusbio.com/fullsize/CD40-TNFRSF5-Antibody-8B8-Immunohistochemistry-NBP2-46150-img0011.jpg)